GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
Recognizing exceptional leadership in patient education and clinical skill in the GammaTile procedure
TEMPE, Ariz., July 24, 2025 /PRNewswire/ -- GT Medical Technologies, a medical device company dedicated to improving the lives of patients with brain tumors, today announced UofL Health as the latest GammaTile® Center of Excellence Program designation. GammaTile is offered at both UofL Health – Brown Cancer Center and UofL Hospital in Louisville, Kentucky.
The program recognizes leaders in patient care dedicated to advancing brain tumor treatment. Physicians and their institutions who receive this designation have demonstrated an exceptional level of expertise in the GammaTile procedure by meeting specific clinical criteria, annual case minimums, and ongoing education requirements.
The following physicians are now recognized with achievement:
- Adrianna Masters, MD, PhD, Radiation Oncologist
- Akshitkumar Mistry, MD, Neurosurgeon
- Brian Williams, MD, Neurosurgeon
- Keith Sowards, MS, Medical Physicist
"UofL Health and the Department of Neurosurgery at UofL are committed to transforming patients' lives through compassionate patient-centered care, innovative research and education," said Dr. Brian Williams, Director of Brain Tumor & Skull Base Program and Associate Professor at UofL Health. "Recognition as one of the first GammaTile Centers of Excellence in Kentucky reflects our commitment to the community to bring world-class care to the commonwealth."
GammaTile is an innovative form of radiation therapy placed at the time of tumor removal surgery, delivering immediate, targeted radiation to the tumor site when cancer cells are at their lowest levels. Unlike conventional approaches, which often require a delay between surgery and radiation therapy to allow for wound healing, GammaTile eliminates this treatment gap. By delivering immediate, localized radiation directly at the tumor site, it is designed to maximize the treatment's effectiveness against remaining cancer cells and reduce the risk of regrowth.1
About GT Medical Technologies, Inc.
GT Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care.
About GammaTile
GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile provides immediate, localized treatment. This approach targets remaining cancer cells when they are at their lowest levels to help prevent regrowth, while minimizing radiation exposure to healthy brain tissue.
Since its full market launch in the United States in March 2020, GammaTile has been adopted by more than 100 leading centers, underscoring its growing acceptance in both academic and community healthcare settings. For more information, visit gammatile.com and follow @GammaTile on Facebook, Instagram, LinkedIn and X.
Media Contact
Dawn Fallon
New Dawn Communications LLC
Dfallon@newdawncomms.com
732-771-7808
References
View original content to download multimedia:https://www.prnewswire.com/news-releases/gt-medical-technologies-welcomes-new-gammatile-center-of-excellence-program-designation-302513060.html
SOURCE GT Medical Technologies